BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19451398)

  • 1. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway.
    Kroeger KM; Sullivan BM; Locksley RM
    J Leukoc Biol; 2009 Oct; 86(4):769-78. PubMed ID: 19451398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Basophil survival and immunomodulatory function are uniquely regulated by a novel MyD88-dependent pathway.
    Knol EF; Gibbs BF
    J Leukoc Biol; 2009 Oct; 86(4):753-5. PubMed ID: 19797302
    [No Abstract]   [Full Text] [Related]  

  • 3. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.
    Pecaric-Petkovic T; Didichenko SA; Kaempfer S; Spiegl N; Dahinden CA
    Blood; 2009 Feb; 113(7):1526-34. PubMed ID: 18955562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.
    Kondo Y; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Morimoto M; Hayashi N; Hoshino T; Fujimoto J; Nakanishi K
    Int Immunol; 2008 Jun; 20(6):791-800. PubMed ID: 18448455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways activated by a protease allergen in basophils.
    Rosenstein RK; Bezbradica JS; Yu S; Medzhitov R
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4963-71. PubMed ID: 25369937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.
    Yoshimoto T; Tsutsui H; Tominaga K; Hoshino K; Okamura H; Akira S; Paul WE; Nakanishi K
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13962-6. PubMed ID: 10570181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands.
    Schneider E; Machavoine F; Bricard-Rignault R; Levasseur M; Petit-Bertron AF; Gautron S; Ribeil JA; Launay JM; Mecheri S; Côté F; Dy M
    J Allergy Clin Immunol; 2011 Oct; 128(4):864-871.e2. PubMed ID: 21636115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
    Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
    Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion.
    Schwartz C; Turqueti-Neves A; Hartmann S; Yu P; Nimmerjahn F; Voehringer D
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5169-77. PubMed ID: 25404305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-derived IL-4/IL-13 protects mice against fatal Schistosoma mansoni infection independently of basophils.
    Schwartz C; Oeser K; Prazeres da Costa C; Layland LE; Voehringer D
    J Immunol; 2014 Oct; 193(7):3590-9. PubMed ID: 25172500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHIP represses Th2 skewing by inhibiting IL-4 production from basophils.
    Kuroda E; Antignano F; Ho VW; Hughes MR; Ruschmann J; Lam V; Kawakami T; Kerr WG; McNagny KM; Sly LM; Krystal G
    J Immunol; 2011 Jan; 186(1):323-32. PubMed ID: 21131429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
    Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
    J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion.
    Varin A; Mukhopadhyay S; Herbein G; Gordon S
    Blood; 2010 Jan; 115(2):353-62. PubMed ID: 19880493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the Th2-dominant milieu on allergic responses in Der f 1-activated mouse basophils and mast cells.
    Yi MH; Kim HP; Jeong KY; Kim JY; Lee IY; Yong TS
    Sci Rep; 2018 May; 8(1):7706. PubMed ID: 29769546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.
    Suzukawa M; Iikura M; Koketsu R; Nagase H; Tamura C; Komiya A; Nakae S; Matsushima K; Ohta K; Yamamoto K; Yamaguchi M
    J Immunol; 2008 Nov; 181(9):5981-9. PubMed ID: 18941187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
    Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
    J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation.
    Chow JY; Wong CK; Cheung PF; Lam CW
    Cell Mol Immunol; 2010 Jan; 7(1):26-34. PubMed ID: 20029461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLP-76 is required for high-affinity IgE receptor- and IL-3 receptor-mediated activation of basophils.
    Hidano S; Kitamura D; Kumar L; Geha RS; Goitsuka R
    Int Immunol; 2012 Nov; 24(11):719-27. PubMed ID: 22875843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4- and NACHT, LRR and PYD domains-containing protein 3-independent mechanisms of alum enhanced T helper type 2 responses on basophils.
    Huang FJ; Ma YL; Tang RY; Gong WC; Li J; Chen CX; Yin L; Chen XP
    Immunology; 2016 Oct; 149(2):238-51. PubMed ID: 27315109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3.
    Junttila IS; Watson C; Kummola L; Chen X; Hu-Li J; Guo L; Yagi R; Paul WE
    J Allergy Clin Immunol; 2013 Sep; 132(3):704-712.e10. PubMed ID: 23683462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.